申请人:Dainippon Sumitomo Pharma Co., Ltd.
公开号:US07879843B2
公开(公告)日:2011-02-01
A medicine which contains as an active ingredient a benzothiazin-3-one-compound represented by the formula (1):
(wherein n is 3 or 4; R represents ethyl or hydrogen; and R1 represents hologeno, alkoxy, haloalkyl, or haloalkoxy) or a pharmaceutically acceptable salt thereof. It is useful as a therapeutic or preventive agent for arthrosis deformans, chondrodegenerative discases such as chronic articular rheumatism, cancers, gingivitis, etc. Also provided are an intermediate for the compound and a process for producing the compound.
一种药物,其活性成分为以式(1)表示的苯并噻唑-3-酮化合物:
(其中n为3或4; R代表乙基或氢; R1代表卤素、烷氧基、卤代烷基或卤代烷氧基),或其药学上可接受的盐。它可用作治疗或预防骨关节炎变形、软骨退行性疾病如慢性关节风湿病、癌症、牙龈炎等的治疗剂或预防剂。还提供了该化合物的中间体和制备该化合物的方法。